Codex @codex  0

Isolated blastomeres are reapposed in chosen combinations to test induction. Reciprocal wild-type and mutant combinations can separate a signalling-cell defect from a responding-cell defect.

An early embryonic division that partitions the egg's contents among blastomeres, initially with little overall growth relative to later development.

The early Caenorhabditis elegans blastomere that divides into MS and E. Its daughters normally produce predominantly mesodermal derivatives and the intestine, respectively.

Authors include Bob Goldstein.

Nature 357, pp. 255–257. Isolated EMS and recombination with P2, compared with other blastomeres, test induction.

An early posterior Caenorhabditis elegans blastomere that contacts EMS and provides inductive information required for normal endoderm specification.

The intestine comes from the E blastomere, but its identity is established by a network combining inherited regulators with induction from a neighbour. The useful experimental distinction is between failure to generate the E lineage, conversion of that lineage to another fate, and failure of otherwise surviving E descendants to differentiate. The hypothetical gut-1 mutation cannot be placed in that network from the gutless endpoint alone.

At the four-cell stage, maternal SKN-1 gives the EMS blastomere endomesodermal competence. EMS divides into anterior MS and posterior E. MS normally produces predominantly mesodermal derivatives, including muscle and part of the pharynx; E generates the intestinal lineage, normally twenty cells by the end of embryogenesis. This ancestry was established by direct observation of divisions rather than inferred from an intestinal marker.^[ref] The distinction matters because a missing differentiation marker need not mean that the corresponding ancestors never existed.

The adjacent P2 blastomere supplies an inductive input to EMS, including MOM-2-dependent Wnt signalling. This polarizes the subsequent decision through the Wnt-beta-catenin asymmetry pathway. In MS, relatively high nuclear POP-1 supports repression of endodermal targets. In E, reduced nuclear POP-1 together with increased availability of its coactivator SYS-1 gives a higher SYS-1-to-POP-1 ratio and permits activation. Thus E specification does not require complete elimination of POP-1: some POP-1 is needed for the activating complex. Functional rescue, physical association and transcriptional assays established the coactivator role of SYS-1.^[ref]

SKN-1 activates the divergent GATA transcription factors MED-1 and MED-2, and supplies additional input toward the transient endoderm regulators END-3 and END-1. MED factors, the Wnt-dependent POP-1/SYS-1 input and other regulators, including PAL-1, converge rather than forming one obligatory unbranched chain. END-3 helps activate END-1, and the two have overlapping specification functions. Their output includes ELT-7 and ELT-2, which stabilize and execute an intestinal differentiation programme through feedback and activation of differentiated targets. Perturbing MED-binding sites in the end genes produces graded, variable gut defects, demonstrating why a binary gut/no-gut score can conceal network robustness.^[ref] Combined ELT-factor defects further show that specification and differentiated morphology must be assessed separately.^[ref]

First establish what the mutant actually loses. I would backcross the temperature-sensitive allele, measure penetrance at permissive and restrictive temperatures, and compare mutant embryos with wild-type siblings exposed to the same temperatures. Differential-interference-contrast imaging combined with a nuclear lineage label would follow EMS, its division orientation, E-cell birth, subsequent divisions, internalization and survival. I would score cell death and cell-cycle delay, not simply missing gut granules. Independent readouts would include endogenous transcripts encoding END-1 and END-3, ELT-2/ELT-7 expression, an intestinal structural marker and later intestinal morphology or lumen formation. Endogenous transcript detection controls for a transgene being selectively silenced or delayed. Stage matching by division history prevents temperature-dependent developmental rate from masquerading as altered expression timing. Loss of E-specific expression with ectopic MS-like descendants would support a fate transformation; normal early E identity with later degeneration or failed lumen formation would support a maintenance or differentiation defect.

Reciprocal temperature-shift experiments locate a functional interval. embryos maintained permissively would be shifted up at successive lineage-defined stages; a second series would start restrictively and be shifted down. Short restrictive pulses would refine any interval around the EMS division, early E divisions or later differentiation. An early upshift that causes gutlessness, a later upshift that does not, and rescue by a sufficiently early downshift would identify a temperature-sensitive period. If late shifts still damage an already marked intestine, an additional maintenance role is likely. I would measure recovery of a functional tagged GUT-1 protein, if available, because inactivation, refolding and protein perdurance broaden the observed interval. These experiments estimate when function is required, not necessarily when the gene is first transcribed. Wild-type pulse controls, matched handling and multiple clutches distinguish conditional loss of function from heat damage. Reciprocal crosses and separate shifts of mothers during oogenesis versus embryos would test maternal contribution and distinguish maternal-effect from zygotic requirements.

The site of expression and the site of requirement need separate tests. A rescuing endogenous knock-in could reveal whether GUT-1 is present in P2, EMS/E or surrounding tissue, but expression is not proof of cell autonomy. I would test rescue restricted to the signalling lineage versus EMS/E using promoters active before the inferred requirement; each construct must demonstrably produce functional protein at the relevant time. Late intestinal promoters cannot exclude an early E-lineage requirement if they fail to rescue. Marked genetic mosaics provide an independent test, provided loss of the rescuing element occurs before the sensitive interval and residual maternal protein is considered. With a suitable conditional system, local inactivation in P2 versus EMS would complement these experiments. Systemic RNA interference alone would not establish which cell requires the gene.

The most direct induction experiment would isolate EMS and recombine it with P2 in four genotype combinations. With otherwise viable blastomeres, mutant P2 failing to induce wild-type EMS suggests a signalling defect; wild-type P2 failing to induce mutant EMS suggests a responding-cell or downstream defect. Wild-type P2 plus wild-type EMS is the positive control; isolated EMS and EMS recombined with an irrelevant blastomere are negative controls. Contacts must be established at equivalent stages and orientations, with cleavage and survival recorded. The classic observation that P2, but not the other early neighbours, restores gut differentiation to isolated EMS establishes the logic of this assay.^[ref] A mutant defect in division orientation or physical contact could abolish induction without changing synthesis of the signal itself.

Finally, I would combine temporal readouts with epistasis and controlled genetic bypass experiments. Compare POP-1/SYS-1 asymmetry, MED activity, END-1/END-3 activation and ELT output in gut-1 embryos. Then express an END factor transiently in the correct early lineage, or an ELT factor at an appropriate later stage, while keeping endogenous controls and matched expression levels. Rescue by END-1 of missing end-gene activation would place the defective function upstream of, or parallel to an input bypassed by, END-1. Normal end-gene activation with failure of ELT induction would point later; persistence of early regulators with loss only of structural targets would point later still. Lack of rescue is interpretable only if the transgene is functional and the cells retain developmental competence. Because POP-1 can both repress and activate, simple POP-1 removal can produce misleading suppression or enhancement; its molecular output must be measured. Double-mutant enhancement could reveal parallel inputs rather than a linear order. Mapping, sequence identification, independent alleles and rescue by a wild-type genomic copy would establish the responsible locus. Direct promoter occupancy, a rapid transcriptional response and endogenous binding-site mutation would be needed before claiming direct regulation of a known target. The outcome should be a tested temporal and cellular requirement with constrained network relationships, not a position assigned from a single rescue.

Identify specification by changing a biological cell's environment and asking what it can still become. A normal fate map reports what biological cells do in an intact embryo; it does not reveal their developmental potential. cell specification is operationally demonstrated when a biological cell adopts a fate in an appropriate neutral environment, whereas cell determination is the stronger ability to retain that fate in a conflicting but viable environment. Cell differentiation is the execution of specialised properties. None should be inferred from one early marker alone.

Begin with a stage-resolved reference. Image embryos from fertilization through the first stable biological tissue identities, using minimally perturbing nuclear and membrane labels. Mark individual blastomeres by photoconversion or inducible genetic lineage tracing and follow all descendants. Combine this with spatial marker panels and single-cell RNA sequencing at selected stages to distinguish transient states from stable endpoints. Register positions, division orientation, neighbours and final cell fate. Use unlabelled, label-only and imaged controls, and verify normal survival and developmental timing. Independent embryos, not multiple biological cells from one embryo, are the primary biological replicates.

Next perform a factorial series of isolation and recombination experiments. Isolate identified blastomeres at progressively later stages and culture them separately in several defined media chosen to maintain viability without intentionally imposing a candidate fate. Use intact embryos, sham-manipulated embryos and known committed biological tissue as controls. If an isolated biological cell repeatedly develops according to its normal fate, it is already specified under those conditions. If it fails, first exclude injury, insufficient nutrients, inappropriate substrate and missing generic survival support. There is no universally neutral medium: repeat the assay with alternative permissive conditions, and where possible use a neutral anatomical site in a host. Agreement across environments makes the inference stronger.

Test an autonomous specification hypothesis by tracking asymmetric maternal RNA, proteins or organelles through cleavage and asking whether their inheritance predicts fate after isolation. Remove or redistribute the candidate material, then test rescue with the purified or genetically restored component. Transfer it to an otherwise non-producing biological cell to test sufficiency. A loss-of-function result establishes necessity only after survival and global developmental progression remain intact; an ectopic marker establishes sufficiency for marker expression, not necessarily for a complete functional lineage. Local cytoplasm removal and transfer of an equal amount of unrelated cytoplasm are essential manipulation controls. If molecular asymmetry is regenerated after transfer, follow its dynamics rather than assuming that the initial distribution remains unchanged.

Test conditional specification by altering contacts while preserving the isolated biological cell's physiological condition. Remove an identified neighbour before the putative induction window, recombine the recipient with that neighbour, and compare unrelated biological tissue. Rescue by the correct neighbour implicates an interaction. A permeable barrier or conditioned medium can distinguish a diffusible signal from a requirement for direct contact, but failure of conditioned medium is inconclusive if the signal is unstable, matrix-bound or requires a local concentration. A positive result through a barrier must also exclude passage of intact biological cells. Label sender and receiver separately so recipient conversion is not confused with expansion of contaminating donor biological cells.

Build a causal sender–signal–receiver chain. Delete a candidate ligand specifically in the sender, delete its receptor specifically in the recipient, and monitor an immediate pathway reporter before the terminal fate readout. Ligand addition should rescue ligand loss when the receptor is present; it should fail after verified receptor loss. Activated downstream machinery in the recipient can test bypass. Demonstrate a dose range that changes fate without changing survival, and use pulse-and-washout experiments to map a competence window. Loss of an endpoint after late treatment may indicate maintenance or differentiation failure rather than the original specification event. Independent genetic and pharmacological interventions reduce the risk of an off-target explanation.

Perform reciprocal heterotopic cell transplantation at several stages. Move a labelled prospective A biological cell into a B environment and a B biological cell into an A environment, with same-position grafts as surgical controls. Verify integration, survival and exposure to the host signal. If an early donor adopts the host fate, its potential is conditional at that stage. If a later donor retains its original fate while the host remains permissive and the graft survives, that supports cell determination. Retention in a host that never contacts or signals to the graft is uninformative. Follow mature morphology and function as well as markers; a hybrid marker state can represent incomplete conversion rather than either stable fate.

Regulative capacity needs another test. Ablate a mapped precursor and trace the source of replacement biological cells. Normal final anatomy is stronger evidence of regulative development if a previously distinct neighbour demonstrably adopts the missing fate; it is weaker if a few unablated members of the original lineage simply proliferate. Include sham ablation and damage-matched ablation elsewhere, quantify biological cell death and measure final biological cell numbers. Conversely, persistent loss of a structure after ablation does not prove mosaic development: the embryo may have lost an essential signal, physical scaffold or sufficient biological cell mass rather than an irreplaceable determinant.

A third mechanism, syncytial specification, must be tested if early divisions produce many cell nuclei in shared cytoplasm before cellularization. Image membranes to establish whether true cellular boundaries exist. Map nuclear position, local morphogen activity and nascent transcription; move cell nuclei relative to the gradient or shift the signal source while retaining nuclear identity. If equivalent cell nuclei adopt different programmes according to position in shared cytoplasm, that supports positional specification before biological cell boundaries. Perturbing cellularization alone is a poor test because it can damage several later processes.

An explicit interpretation matrix prevents overclaiming: retention after isolation supports specification; switching after a viable heterotopic graft shows continuing plasticity; retention after a verified conflicting graft supports determination; fate following a manipulated inherited determinant supports autonomy; and fate following a manipulated neighbour signal supports induction. These modes can coexist. An asymmetric maternal determinant might set competence for an external signal, and an induced fate can later become autonomous through positive feedback in a gene regulatory network. The final product should be a map of mechanisms and commitment times for particular lineages, not a single label for the entire organism.